X-ZELL technology on show at SWITCH X SSF 2019

Singapore, October 2019 – X-ZELL has been selected as one of the start-ups to be featured on A*ccelerate Technologies’ Innovation Pavilion at the upcoming SWITCH exhibition in Singapore.

Short for Singapore Week of Innovation and Technology, SWITCH first came to life in 2018 as a platform to showcase Singapore’s vibrant entrepreneurial and technology innovation ecosystem. 

In 2019, the landmark event – comprising of a conference, exhibition as well as a series of industry and innovation events – will be held in conjunction with the Singapore FinTech Festival (SFF), one of the largest financial technology summits in the world.

The move is expected to create synergies across a broad spectrum of sectors ranging from Advanced Manufacturing & Engineering, Urban Solutions & Sustainability, Health & Biomedical Sciences and Services & Digital Economy through to FinTech.

In 2018, the two events drew close to 57,000 delegates from almost 130 countries in 2018.

A*ccelerate Technologies – the commercialisation arm of the Agency for Science, Technology and Research (A*STAR) – will make full use of the combined potential by presenting some of the nation’s most promising innovators on a joint stand at the heart of the exhibition area.

X-ZELL, which has been partnering with A*ccelerate Technologies’ Diagnostics Development (DxD) Hub since December 2018, has been selected as one of them.

Ranked among Asia’s 50 most innovative health tech start-ups for two years running, the Singapore-based company is fusing next-generation cell detection technology with cutting-edge AI to detect traces of early-stage cancer in small, 10mL blood samples. 

Date:               11-13 Nov 2019
Venue:            Singapore Expo
Booth:             5K 17
More:              www.switchsg.org

 

Media Contact:
Sebastian Grote
Head of Strategy, Marketing & Communications
+65 9630 0706
sebastian.g@x-zell.com

X-ZELL
Next-generation cytology

© 2024 X-ZELL Biotech Pte. Ltd.

Find Us

XZELL HQ